《大行報告》大摩上調信義光能(00968.HK)目標價至17.3元 評級「增持」
摩根士丹利發表報告,將信義光能(00968.HK)目標價由16.6元上調至17.3元,相當預測今年市盈率30.6倍,以反映對集團2025年至2027年每股盈測的調升,維持「增持」評級。
該行表示,由於預期今年的需求強勁,及天然氣和純鹼價格上升導致生產成本增加,將信義光能的太陽能玻璃產品均價預測上調。另外,根據最新的太陽能電場安裝假設,及集團的最新指引,將信義光能今年每股盈利預測調升2%,但對其2023年及2024年每股盈利預測則分別降低4%及2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.